However, since we have not directly compared the pathogenic impact of the syndrome and cancer-associated mutations of RECQL on its enzymatic activities and roles in regulating DNA replication, we acknowledge that it is difficult to make any conclusions regarding whether the p.A459S mutation may predispose individuals to breast cancer. This evidence concerns the gene RECQL and cancer.